ABBV AbbVie Inc. stock chart & analysis
Conviction 56HealthcareScan · Fri, Nov 6, 2026AbbVie Inc. (ABBV) closed at $291.31 (+1.07%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 60, RS Rating 92, -3.9% from its 52-week high, +27.5% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Financials as of Wed, Sep 30, 2026 · quarterly.
ABBV technical analysis
Trend
ABBV is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 7.1% above the 50-day ($271.95) and 21.9% above the 200-day ($238.94). ADX(14) at 31 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 60, in the bullish half of its range. MACD crossed below its signal line 3 sessions ago. A bearish MACD divergence is in place. Its RS Rating of 92 puts its weighted 12-month performance ahead of about 92% of the US market, and its RS line is at a new high.
Volume and volatility
Volume on the latest session ran 0.7× its 20-day average. It trades about $1.6B a day on average. ATR(14) is $7.75, 2.7% of price — its typical daily range. Bollinger Bands are in a squeeze — volatility is compressed.
Key levels
The chart pattern's support is $267.94 and its resistance $295.07. The 52-week range is $190.75 to $302.93; price is 3.9% below the high and 52.7% above the low. The VWAP anchored at the 52-week high is $291.39, above price.
Performance
ABBV returned -1.2% (1 week), +6.9% (1 month), +17.4% (3 months), +44.5% (6 months), +34.4% (1 year), +27.5% (year to date).
About AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Pharmaceutical Preparations · Listed 2012 · 57,000 employees
Congress activity
Disclosed STOCK Act trades in ABBV · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Pete Sessions house · R · TX · traded 2026-09-14 | Sell | $15K–$50K | 2026-09-14 | 2026-09-18 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $15K–$50K | 2026-03-27 | 2026-07-21 | |
 Josh Gottheimer house · NJ · traded 2026-05-05 | Sell | $1K–$15K | 2026-05-05 | 2026-06-02 | |
 Julia Letlow house · LA · traded 2025-12-08 | Sell | $1K–$15K | 2025-12-08 | 2026-01-01 | |
 Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
 John Boozman senate · R · AR · traded 2025-08-22 | Sell | $1K–$15K | 2025-08-22 | 2025-09-12 | |
John Boozman senate · R · AR · traded 2025-08-11 | Sell | $1K–$15K | 2025-08-11 | 2025-09-12 | |
 Julie Johnson house · D · TX · traded 2025-08-14 | Sell | $1K–$15K | 2025-08-14 | 2025-09-11 | |
 Ritchie John Torres house · D · NY · traded 2024-09-26 | Buy | $1K–$15K | 2024-09-26 | 2025-08-20 | |
Ritchie John Torres house · D · NY · traded 2025-07-11 | Sell | $1K–$15K | 2025-07-11 | 2025-08-20 |
Insider activity
SEC Form 4 transactions in ABBV · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
RAPP EDWARD J Director · Stock Equivalent Units · 2026-09-30 | Grant | 129 | $34K | 2026-09-30 | 2026-10-02 |
Quaggin Susan E Director · Stock Equivalent Units · 2026-09-30 | Grant | 59 | $15K | 2026-09-30 | 2026-10-02 |
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER · Common Stock, $0.01 par value · 2026-08-14 | Exercise | 32.71K | $2.6M | 2026-08-14 | 2026-08-18 |
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER · Common Stock, $0.01 par value · 2026-08-14 | Sell | 32.71K | $8.2M | 2026-08-14 | 2026-08-18 |
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER · Option (Right to buy) · 2026-08-14 | Exercise | 32.71K | — | 2026-08-14 | 2026-08-18 |
AUSTIN ROXANNE S Director · Common Stock, $0.01 par value · 2026-05-08 | Grant | 1.12K | $0 | 2026-05-08 | 2026-05-12 |
WADDELL FREDERICK H Director · Common Stock, $0.01 par value · 2026-05-08 | Grant | 1.12K | $0 | 2026-05-08 | 2026-05-12 |
FALK THOMAS J Director · Common Stock, $0.01 par value · 2026-05-08 | Grant | 1.12K | $0 | 2026-05-08 | 2026-05-12 |
BURNSIDE WILLIAM H.L. Director · Common Stock, $0.01 par value · 2026-05-08 | Grant | 1.12K | $0 | 2026-05-08 | 2026-05-12 |
RAPP EDWARD J Director · Common Stock, $0.01 par value · 2026-05-08 | Grant | 1.12K | $0 | 2026-05-08 | 2026-05-12 |
SEC filings
EDGAR filings in ABBV · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.